Merck & Co., Inc. (ETR:6MK)
Germany · Delayed Price · Currency is EUR | Market Cap | 207.15B |
| Revenue (ttm) | 54.75B |
| Net Income (ttm) | 16.22B |
| Shares Out | n/a |
| EPS (ttm) | 6.44 |
| PE Ratio | 12.77 |
| Forward PE | 10.73 |
| Dividend | 2.86 (3.39%) |
| Ex-Dividend Date | Dec 15, 2025 |
| Volume | 787 |
| Average Volume | 3,116 |
| Open | 83.80 |
| Previous Close | 83.40 |
| Day's Range | 83.60 - 84.40 |
| 52-Week Range | 65.50 - 99.10 |
| Beta | 0.30 |
| RSI | 50.33 |
| Earnings Date | Feb 3, 2026 |
About Merck & Co.
Merck & Co., Inc. operates as a healthcare company worldwide. The company offers human health pharmaceutical for various areas under the Keytruda, Welireg, Gardasil, ProQuad, M−M−R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, B... [Read more]
Financial Performance
In 2024, Merck & Co.'s revenue was $64.17 billion, an increase of 6.74% compared to the previous year's $60.12 billion. Earnings were $17.12 billion, an increase of 4589.59%.
Financial numbers in USD Financial StatementsNews
Should You Buy the 5 Highest-Paying Dividend Stocks in the Dow Jones Before 2026?
The Dow Jones tracks 30 of the largest American companies across different sectors. Verizon, Chevron, and Merck hold the highest dividend yields in the Dow Jones.
Dow Movers: MRK, DIS
In early trading on Tuesday, shares of Walt Disney topped the list of the day's best performing Dow Jones Industrial Average components, trading up 1.3%. Year to date, Walt Disney registers a 0.5% gai...
Merck's (MRK) KEYTRUDA Receives FDA Fast Track Designation in Combination Therapy
Merck's (MRK) KEYTRUDA Receives FDA Fast Track Designation in Combination Therapy
Why Adagene Is Rising In Pre-market?
(RTTNews) - Adagene Inc. (ADAG) announced that the FDA has designated muzastotug, in combination with Merck's anti-PD-1 therapy, KEYTRUDA, as a Fast Track product for adult patients with microsatellit...
Merck (MRK) Experiences Modest Bearish Sentiment Among Option Traders
Merck (MRK) Experiences Modest Bearish Sentiment Among Option Traders
Merck & Co's Options: A Look at What the Big Money is Thinking
Financial giants have made a conspicuous bearish move on Merck & Co. Our analysis of options history for Merck & Co (NYSE: MRK) revealed 17 unusual trades. Delving into the details, we found 35% of t...
Should You Forget Teva Pharmaceutical and Buy These Unstoppable Stocks Instead?
Shares of Teva -- a generic-drug maker with a history of losses and high leverage -- have rallied strongly. Pfizer and Merck, which make branded drugs, are financially strong and are rebuilding their ...
Merck & Co (MRK) Analyst Ratings Update: Morgan Stanley Raises Price Target | MRK Stock News
Merck & Co (MRK) Analyst Ratings Update: Morgan Stanley Raises Price Target | MRK Stock News
Here Are 2 Affordable Healthcare Stocks to Buy Heading Into 2026
One of these pharmaceutical leaders overcame a major obstacle and has a strong outlook. The other is actively pushing greater innovation to get around a rapidly approaching patent cliff.
Can MRK's New Drugs & Pipeline Help Navigate the Looming Keytruda LOE?
Merck leans on a fast-growing pipeline and new product launches to aid long-term growth as Keytruda's 2028 LOE nears.
Merck (MRK) Awaits EU Decision on Expanded Winrevair Use
Merck (MRK) Awaits EU Decision on Expanded Winrevair Use
Merck & Co., Inc.: Merck Receives Positive EU CHMP Opinion for Expanded Use of WINREVAIR (sotatercept) in Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1 Pulmonary Hypertension)
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) recommended the ...
Merck Receives Positive EU CHMP Opinion for Expanded Use of WINREVAIR (sotatercept) in Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1 Pulmonary Hypertension)
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended the appr...
Merck Receives Positive EU CHMP Opinion for Expanded Use of WINREVAIR™ (sotatercept) in Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1 Pulmonary Hypertension)
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the European Medicines Agency's Committee for Medicinal Products for Human ...
Ex-Dividend Reminder: Gilead Sciences, Merck and Horace Mann Educators
Looking at the universe of stocks we cover at Dividend Channel, on 12/15/25, Gilead Sciences Inc (Symbol: GILD), Merck & Co Inc (Symbol: MRK), and Horace Mann Educators Corp. (Symbol: HMN) will all tr...
Merck (MRK) Sees Notable Increase in Indicative Borrow Rate
Merck (MRK) Sees Notable Increase in Indicative Borrow Rate
Noteworthy ETF Inflows: VIG, IBM, MRK, MCD
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard Dividend Appreciation ETF (Symbol: VIG) where we have detecte...
2 Pharmaceutical Stocks to Buy at a Discount
Weight loss drugs are the big story in the pharmaceutical industry today, but other opportunities exist, too. Bristol Myers Squibb isn't focused on weight loss, has an attractive yield, and continues ...
FDA approves Merck drug for decimated U.S. cattle herds to stop screwworm
The U.S. Food and Drug Administration granted conditional approval for a Merck Animal Health pour-on treatment for the prevention and treatment of New World Screwworm, with farmers able to receive dos...
Here's 1 Major Catalyst Behind Merck Stock's Recent 3.8% Bump
The company is finding ways to overcome the headwinds it will encounter in the medium term.
MRK Stock Trading Above 200- & 50-Day SMA for 2 Months: Time to Buy?
Merck holds bullish momentum as pipeline advances and major deals offset vaccine weakness and Keytruda risks.
1 Major Factor Behind the Healthcare Sector's Recent Surge
Eli Lilly's GLP-1 drug became the world's best-selling drug in Q3. Merck, Johnson & Johnson, AbbVie, and other companies are soaring on new drugs or the growth of existing ones.
BenchSci Extends ASCEND Agreement with Merck to Support Preclinical Disease Biology Research
TORONTO--(BUSINESS WIRE)--BenchSci, a leading provider of AI software for biopharma research and development, today announced a renewed two-year contract with Merck, known as MSD outside of the United...
Formycon and Zydus partner for exclusive licensing and supply agreement of FYB206, a biosimilar to Keytruda® (Pembrolizumab), in the U.S. and Canada
PLANEGG-MARTINSRIED, Germany and AHMEDABAD, India, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Formycon AG (FSE: FYB, “Formycon”) and Zydus Lifesciences Limited (including its subsidiaries and affiliates, “Zydu...
Noteworthy Monday Option Activity: ADBE, MRK, GLW
Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in Adobe Inc (Symbol: ADBE), where a total of 25,838 contracts have traded so far, representing app...